Predictive value of BubR1 and synuclein- gamma expression in breast cancer.

被引：0
|
作者：
Cirak, Yalcin
Furuncuoglu, Yavuz
Yapicier, Ozlem
Argon, Andac
Alici, Suleyman
机构：
[1] Bahcesehir Univ, Sch Med, Div Med Oncol, Istanbul, Turkey
[2] Goztepe Med Pk Hosp, Istanbul, Turkey
[3] Bahcesehir Univ, Sch Med, Div Pathol, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e13511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13511
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer.
    Kneubil, Maximiliano Cassilha
    Goulart, Karen Olivia Bazzo
    Brollo, Janaina
    Coelho, Guilherme Portela
    Mandelli, Jovana
    Orlandin, Bruna Caroline
    Corso, Leandro Luis
    Roesch-Ely, Mariana
    Henriques, Joao Antonio Pegas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators
    Pun, Renju
    Thapa, Aradhana
    Takafuji, Sylar R.
    Suzuki, Rexton M.
    Kay, Gabrielle F.
    Howard, Toni D.
    Kim, Michael H.
    North, Brian J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (06):
  • [23] Immunohistochemical Validation of Topoisomerase 2 alpha and BubR1 as Novel Breast Cancer Risk Genes in Benign Breast Tissue
    Nasir, A.
    Chen, D. T.
    Culhane, A. C.
    Gruidl, M.
    McCarthy, S. M.
    Venkataramu, C.
    Quackenbush, J.
    Yeatman, T. J.
    MODERN PATHOLOGY, 2009, 22 : 58A - 58A
  • [24] Mad2 and BubR1: chemotherapeutic coordinators in gastric cancer
    Iimori, Makoto
    Kitao, Hiroyuki
    Maehara, Yoshihiko
    CELL CYCLE, 2015, 14 (07) : 946 - 946
  • [25] Immunohistochemical Validation of Topoisomerase 2 alpha and BubR1 as Novel Breast Cancer Risk Genes in Benign Breast Tissue
    Nasir, A.
    Chen, D. T.
    Culhane, A. C.
    Gruidl, M.
    McCarthy, S. M.
    Venkataramu, C.
    Quackenbush, J.
    Yeatman, T. J.
    LABORATORY INVESTIGATION, 2009, 89 : 58A - 58A
  • [26] BubR1 and AURKB overexpression are associated with a favorable prognosis in gastric cancer
    Enjoji, Megumu
    Ilda, Satoru
    Sugita, Hirofumi
    Ishikawa, Toshiaki
    Uetake, Hiroyuki
    Inokuchi, Mikito
    Yamada, Hiroyuki
    Kojima, Kazuyuki
    Sugihara, Kenichi
    MOLECULAR MEDICINE REPORTS, 2009, 2 (04) : 589 - 596
  • [27] Differential promoter methylation may be a key molecular mechanism in regulating BubR1 expression in cancer cells
    Park, Hye-Young
    Jeon, Yoon-Kyung
    Shin, Hyun-Jin
    Kim, Il-Jin
    Kang, Hio-Chung
    Jeong, Sook-Jung
    Chung, Doo-Hyun
    Lee, Chang-Woo
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2007, 39 (02): : 195 - 204
  • [28] BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer
    Pun, Renju
    Kumari, Niti
    Monieb, Rodaina Hazem
    Wagh, Sachin
    North, Brian J.
    SEMINARS IN CANCER BIOLOGY, 2024, 106 : 201 - 216
  • [29] Differential promoter methylation may be a key molecular mechanism in regulating BubR1 expression in cancer cells
    Hye-Young Park
    Yoon-Kyung Jeon
    Hyun-Jin Shin
    Il-Jin Kim
    Hio-Chung Kang
    Sook-Jung Jeong
    Doo-Hyun Chung
    Chang-Woo Lee
    Experimental & Molecular Medicine, 2007, 39 : 195 - 204
  • [30] Downregulation of BUBR1 regulates the proliferation and cell cycle of breast cancer cells and increases the sensitivity of cells to cisplatin
    Yiran Lu
    Ruiqing Wang
    Song He
    Qing Zhang
    Jiahui Wei
    Jinping Hu
    Yu Ding
    In Vitro Cellular & Developmental Biology - Animal, 2023, 59 : 778 - 789
12345